# 68Ga-FAPI-46 PET/CT for the Prediction of Clinical Response to Neoadjuvant Therapy in Nasopharyngeal Carcinoma Patients

> **NCT07139054** · — · COMPLETED · sponsor: **The First Affiliated Hospital of Xiamen University** · enrollment: 31 (actual)

## Conditions studied

- Nasopharyngeal Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07139054
- **Lead sponsor:** The First Affiliated Hospital of Xiamen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-31
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-08-10
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2025-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07139054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07139054, "68Ga-FAPI-46 PET/CT for the Prediction of Clinical Response to Neoadjuvant Therapy in Nasopharyngeal Carcinoma Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07139054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*